Precision BioSciences's total assets for Q4 2024 were $136.39M, a decrease of -11.01% from the previous quarter. DTIL total liabilities were $80.00M for the fiscal quarter, a -9.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.